Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 367

1.

Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.

Sernyak MJ, Rosenheck RA.

Psychiatr Serv. 2008 May;59(5):567-9. doi: 10.1176/appi.ps.59.5.567.

PMID:
18451019
[PubMed - indexed for MEDLINE]
2.

From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.

Leslie DL, Rosenheck RA.

Am J Psychiatry. 2002 Sep;159(9):1534-40.

PMID:
12202274
[PubMed - indexed for MEDLINE]
3.

Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.

Leslie DL, Mohamed S, Rosenheck RA.

Psychiatr Serv. 2009 Sep;60(9):1175-81. doi: 10.1176/appi.ps.60.9.1175.

PMID:
19723731
[PubMed - indexed for MEDLINE]
4.

Association of co-morbidities with prescribing patterns and cost savings: olanzapine versus risperidone for schizophrenia.

Yu W, Ren XS, Lee AF, Herz L, Huang YH, Kazis LE.

Pharmacoeconomics. 2006;24(12):1233-48.

PMID:
17129077
[PubMed - indexed for MEDLINE]
5.

Racial disparity in the use of atypical antipsychotic medications among veterans.

Copeland LA, Zeber JE, Valenstein M, Blow FC.

Am J Psychiatry. 2003 Oct;160(10):1817-22.

PMID:
14514496
[PubMed - indexed for MEDLINE]
6.

Pharmacotherapy and health care costs among patients with schizophrenia and newly diagnosed diabetes.

Leslie DL, Rosenheck RA.

Psychiatr Serv. 2005 Jul;56(7):803-9.

PMID:
16020811
[PubMed - indexed for MEDLINE]
7.

The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.

Leslie DL, Rosenheck R.

J Nerv Ment Dis. 2001 Jun;189(6):377-83.

PMID:
11434638
[PubMed - indexed for MEDLINE]
8.

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.

Citrome L, Jaffe A, Levine J, Allingham B, Robinson J.

Psychiatr Serv. 2004 Sep;55(9):1006-13.

PMID:
15345760
[PubMed - indexed for MEDLINE]
9.

[Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].

Brunot A, Lachaux B, Sontag H, Casadebaig F, Philippe A, Rouillon F, Cléry-Melin P, Hergueta T, Llorca PM, Moreaudefarges T, Guillon P, Lebrun T.

Encephale. 2002 Mar-Apr;28(2):129-38. French.

PMID:
11972139
[PubMed - indexed for MEDLINE]
10.

Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population.

Hsu C, Ried LD, Bengtson MA, Garman PM, McConkey JR, Rahnavard F.

J Am Pharm Assoc (2003). 2008 May-Jun;48(3):393-400. doi: 10.1331/JAPhA.2008.07007.

PMID:
18595825
[PubMed - indexed for MEDLINE]
11.

A regional comparison of developing diabetes among VA patients exposed to typical and atypical antipsychotics relative to corticosteroids and proton pump inhibitors.

Barnett M, Argo T, Alexander B, Perry P.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):1-7.

PMID:
16517447
[PubMed - indexed for MEDLINE]
12.

Factors related to antipsychotic oversupply among Central Texas Veterans.

Yang M, Barner JC, Worchel J.

Clin Ther. 2007 Jun;29(6):1214-25.

PMID:
17692735
[PubMed - indexed for MEDLINE]
13.

Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review.

Valenstein M, Ganoczy D, McCarthy JF, Myra Kim H, Lee TA, Blow FC.

J Clin Psychiatry. 2006 Oct;67(10):1542-50.

PMID:
17107245
[PubMed - indexed for MEDLINE]
14.

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.

Leslie DL, Rosenheck RA.

Am J Psychiatry. 2004 Sep;161(9):1709-11.

PMID:
15337666
[PubMed - indexed for MEDLINE]
15.

Duration of pharmacotherapy with long-acting injectable risperidone in the treatment of schizophrenia.

Mohamed S, Rosenheck R, Harpaz-Rotem I, Leslie D, Sernyak MJ.

Psychiatr Q. 2009 Dec;80(4):241-9. doi: 10.1007/s11126-009-9111-9. Epub 2009 Sep 19.

PMID:
19768543
[PubMed - indexed for MEDLINE]
16.

Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia.

Garman PM, Ried LD, Bengtson MA, Hsu C, McConkey JR.

J Am Pharm Assoc (2003). 2007 May-Jun;47(3):373-8.

PMID:
17510032
[PubMed - indexed for MEDLINE]
17.

Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.

Barnett MJ, Wehring H, Perry PJ.

J Clin Psychopharmacol. 2007 Dec;27(6):595-601.

PMID:
18004126
[PubMed - indexed for MEDLINE]
18.

Administrative prescription review procedures and use of atypical antipsychotic medications in the Department of Veterans Affairs.

Rosenheck R, Leslie D.

Ment Health Serv Res. 2003 Sep;5(3):149-53.

PMID:
15224448
[PubMed - indexed for MEDLINE]
19.

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

Wheeler AJ.

Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.

PMID:
18477732
[PubMed - indexed for MEDLINE]
20.

Antipsychotic medication utilization trends among Texas veterans: 1997-2002.

Yang M, Barner JC, Lawson KA, Rascati KL, Wilson JP, Crismon ML, Worchel J, Mascarenas CA.

Ann Pharmacother. 2008 Sep;42(9):1229-38. doi: 10.1345/aph.1L155. Epub 2008 Aug 5.

PMID:
18682544
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk